Yasushi Onishi Selected Research

Yasushi Onishi Research Topics

Disease

12	Aplastic Anemia (Anemia, Hypoplastic) 05/2024 - 04/2016
12	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 08/2008
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 02/2013
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 07/2007
10	Infections 08/2021 - 10/2006
9	Multiple Myeloma 01/2024 - 01/2009
8	Lymphoma (Lymphomas) 02/2024 - 08/2013
8	Neoplasms (Cancer) 06/2023 - 10/2008
8	Leukemia 08/2021 - 02/2013
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 07/2011
7	Hematologic Neoplasms (Hematological Malignancy) 03/2021 - 08/2008
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 11/2012
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2023 - 08/2013
4	Philadelphia Chromosome 01/2021 - 07/2011
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2024 - 07/2007
3	Diarrhea 06/2023 - 01/2012
3	Pathologic Complete Response 09/2022 - 07/2009
3	Sideroblastic Anemia 01/2022 - 11/2014
3	Hepatitis 01/2021 - 09/2015
3	Residual Neoplasm 12/2019 - 01/2019
3	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2019 - 01/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2023 - 09/2015
2	Acute Promyelocytic Leukemia 12/2022 - 11/2012
2	COVID-19 10/2022 - 01/2021
2	X-linked sideroblastic anemia 01/2022 - 01/2013
2	Epstein-Barr Virus Infections 01/2022 - 02/2021
2	Bronchiolitis Obliterans Syndrome 12/2021 - 02/2005
2	Disease Progression 02/2021 - 01/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2020 - 01/2018
2	Hodgkin Disease (Hodgkin's Disease) 05/2020 - 05/2017
2	Disseminated Intravascular Coagulation 01/2019 - 05/2017
2	Thrombotic Thrombocytopenic Purpura 01/2017 - 01/2010
2	Anemia 03/2014 - 01/2013
2	Large Granular Lymphocytic Leukemia 01/2010 - 07/2007
1	Congenital Bone Marrow Failure Syndromes 02/2024
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2023
1	Edema (Dropsy) 06/2023
1	Stroke (Strokes) 12/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2022
1	Plasmacytoma 10/2021

Drug/Important Bio-Agent (IBA)

8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 07/2009
7	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2024 - 01/2019
6	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 08/2017
6	Rituximab (Mabthera)FDA Link 01/2020 - 07/2009
5	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024 - 07/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2013
4	AntibodiesIBA 10/2023 - 09/2015
4	Antiviral Agents (Antivirals)IBA 08/2021 - 09/2015
4	Imatinib Mesylate (Gleevec)FDA Link 08/2021 - 04/2014
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020 - 12/2014
3	Calcineurin InhibitorsIBA 02/2024 - 12/2017
3	fludarabineIBA 02/2024 - 04/2016
3	CreatinineIBA 06/2023 - 01/2010
3	EnzymesIBA 11/2022 - 01/2010
3	Brentuximab VedotinIBA 09/2022 - 05/2017
3	Dasatinib (BMS 354825)FDA Link 08/2021 - 06/2017
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 09/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 08/2017
3	CytokinesIBA 01/2016 - 01/2013
2	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 11/2022
2	glasdegibIBA 02/2024 - 08/2017
2	Melphalan (Alkeran)FDA LinkGeneric 02/2024 - 10/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2024 - 01/2021
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2023 - 06/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2012
2	daratumumabIBA 10/2021 - 08/2019
2	Lenalidomide (CC 5013)FDA Link 11/2020 - 10/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 10/2020
2	Prednisolone (Predate)FDA LinkGeneric 10/2020 - 07/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 04/2016
2	ThrombomodulinIBA 01/2019 - 05/2017
2	AcidsIBA 01/2019 - 11/2014
2	HLA-A Antigens (HLA-A)IBA 08/2017 - 05/2013
2	Bortezomib (Velcade)FDA Link 09/2011 - 04/2009
2	Thalidomide (Thalomid)FDA Link 09/2011 - 01/2009
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2024
1	eltrombopag FDA Link 02/2024
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	HLA-DP Antigens (HLA-DP)IBA 10/2023
1	Chimeric Antigen ReceptorsIBA 06/2023
1	tisagenlecleucelIBA 06/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	pevonedistatIBA 11/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2022
1	5-Aminolevulinate SynthetaseIBA 01/2022

Therapy/Procedure

29	Transplantation 02/2024 - 07/2007
25	Hematopoietic Stem Cell Transplantation 05/2024 - 10/2006
15	Therapeutics 02/2024 - 01/2009
13	Drug Therapy (Chemotherapy) 02/2024 - 01/2009
12	Cell Transplantation 02/2024 - 04/2016
7	Stem Cell Transplantation 12/2023 - 01/2004
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2024 - 01/2021
2	Induction Chemotherapy 09/2022 - 02/2019
2	Remission Induction 02/2019 - 01/2010
1	Immunotherapy 06/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2023
1	Activities of Daily Living (ADL) 12/2022
1	Blood Component Removal (Apheresis) 10/2022